XML 17 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Cash flows from operating activities:                
Net income (loss) $ 26,555 $ 12,988 $ 10,361 $ (6,992) $ (5,380) $ 23,349 $ (12,372)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:                
Depreciation and amortization           1,248 1,274  
Inventory impairment charges   0   0   65 322  
Share-based compensation           7,968 0  
Amortization of discount and cost of issuance of debt           198 100  
Bad debts           93 0  
Non-cash interest expense           0 380  
(Gain) loss from change in fair value remeasurement of SAFEs   (2,500)   1,866   (21,600) 2,215  
(Gain) loss from change in fair value of warrants   (11,316)   0   (11,316) 0  
(Gain) loss from change in fair value of earn-out liability   (17,839)   0   (17,839) 0  
(Gain) loss from extinguishment of debt   (304)   0   (304) 0  
Deferred City Semi compensation           250 333  
Changes in operating assets and liabilities:                
Accounts receivable           (1,350) (38)  
Inventory           (530) (1,090)  
Accounts payable           (211) (1,116)  
Accrued expenses and other current liabilities           1,164 (186)  
Deferred revenue           (476) 198  
Prepaid and other current assets           (3,321) (185)  
Other long-term liabilities           479 (558)  
Net cash used in operating activities           (22,133) (10,723)  
Cash flows from investing activities:                
Purchases of property and equipment           (809) (227)  
Accrual for purchases of intangible assets           (43) 0  
Net cash used in investing activities           (852) (227)  
Cash flows from financing activities:                
Proceeds from issuance of SAFEs           5,000 7,875  
Proceeds from sale of noncontrolling interest           0 1,452  
Proceeds from issuance of debt obligations           155 4,966  
Proceeds from reverse recapitalization           377,663 0  
Issuance costs related to reverse recapitalization           (6,215) 0  
Payments on debt obligations           (15,008) (3,423)  
Payments on financed software           (2,227) (270)  
Redemption of Class H units           (900) 0  
Net cash provided by financing activities           358,468 10,600  
Effect of exchange rate changes on cash and cash equivalents           27 3  
Net increase (decrease) in cash and cash equivalents           335,510 (347)  
Cash and cash equivalents at beginning of period     $ 18,698   $ 7,155 18,698 7,155 $ 7,155
Cash and cash equivalents at end of period $ 354,208 $ 354,208   $ 6,808   354,208 6,808 $ 18,698
Supplemental disclosure of cash flow information:                
Cash paid for interest           1,137 780  
Supplemental disclosure of non-cash investing and financing activities:                
Purchases of property and equipment, accrued but not paid           688 161  
Conversion of historical members' equity           41,278 0  
Class G warrants cashless exchange           407 0  
Conversion of SAFEs           86,100 0  
Conversion of Embry Notes           4,119 0  
Recognition of earn-out considerations           119,759 0  
Recognition of warrant liabilities           74,408 0  
Transaction costs accrued but not paid           14,754 0  
Accrual for purchases of intangible assets           $ 12,198 $ 0